Skip to main content
Clinical Trials/NCT00422747
NCT00422747
Completed
Not Applicable

Early Diagnosis of Asthma in Young Children

Maastricht University Medical Center1 site in 1 country202 target enrollmentApril 2007

Overview

Phase
Not Applicable
Intervention
beclomethasondipropionate
Conditions
Asthma
Sponsor
Maastricht University Medical Center
Enrollment
202
Locations
1
Primary Endpoint
- definite asthma diagnosis - biomarkers in exhaled breath
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The overall aim of the study is an early asthma diagnosis in young children by the use of non-invasive biomarkers of airway inflammation /oxidative stress in exhaled air, and early lung function measurements

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
August 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children aged 2-3 years, with recurrent respiratory symptoms suggestive of asthma
  • Children aged 2-3 years, with no or minor respiratory symptoms

Exclusion Criteria

  • Mental retardation
  • Cardiac anomalies
  • Congenital malformations
  • Other diseases of the lungs/airways
  • Chronic systemic inflammatory diseases like M. Crohn
  • The inability to perform lung function measurements and/or exhaled air collection

Arms & Interventions

beclomethasondipropionate

2 x 100 ug dd for two months, via aerochamber

Intervention: beclomethasondipropionate

Outcomes

Primary Outcomes

- definite asthma diagnosis - biomarkers in exhaled breath

Time Frame: 6 years of age

Study Sites (1)

Loading locations...

Similar Trials